+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Analgesics in Canada

  • ID: 4420029
  • Report
  • September 2021
  • Region: Canada
  • 27 Pages
  • Euromonitor International
After a spike in current retail value growth in 2020, systemic analgesics is expected to record more moderate growth in 2021. This is reflective of the way in which Canadians used analgesics during the COVID-19 pandemic for a wide variety of purposes, including core pain relief, symptomatic relief (particularly among elderly Canadians) and pain management while waiting for nonurgent, elective surgery, which was postponed as hospitals prioritised COVID-19 cases.

The publisher's Analgesics in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage:


Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage:


Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?


  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown

KEY DATA FINDINGS
2021 DEVELOPMENTS
  • Analgesics sees robust current value growth in 2021 but at a slower rate than recorded at the height of the pandemic
  • Multinationals leverage extensive distribution and product ranges to lead sales
  • Consumers shift towards e-commerce in response to COVID-19

PROSPECTS AND OPPORTUNITIES
  • An ageing population will continue to bolster sales of analgesics in Canada
  • E-commerce is expected to continue to grow from a small base across the forecast period

CBD topical analgesics are set to perform well in the coming years
CATEGORY DATA
  • Table 1 Sales of Analgesics by Category: Value 2016-2021
  • Table 2 Sales of Analgesics by Category: % Value Growth 2016-2021
  • Table 3 NBO Company Shares of Analgesics: % Value 2017-2021
  • Table 4 LBN Brand Shares of Analgesics: % Value 2018-2021
  • Table 5 Forecast Sales of Analgesics by Category: Value 2021-2026
  • Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026

CONSUMER HEALTH IN CANADA
EXECUTIVE SUMMARY
  • Consumer health in 2021: The big picture
  • 2021 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?

MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
  • Table 8 Life Expectancy at Birth 2016-2021

MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2016-2021
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
  • Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
  • Table 14 Distribution of Consumer Health by Format: % Value 2016-2021
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2021
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2021-2026
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026

APPENDIX
OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches

DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources
Note: Product cover images may vary from those shown